Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
438.77 M USD
2.60 B USD
About NOVONESIS (NOVOZYMES A/S) B
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.